Robertson Stephens Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Robertson Stephens Wealth Management's FBT Position: Q2 2026 in Review
Robertson Stephens Wealth Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.39% in Q2 2026, selling an estimated $3.45K and leaving 4,138 shares worth $1.03M. The position accounts for 0.03% of the portfolio, ranked #310.
Robertson Stephens Wealth Management first reported a position in FBT in Q4 2022 and has held it in 15 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Robertson Stephens Wealth Management held 4,138 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.03M as of Q2 2026.
- Robertson Stephens Wealth Management sold 16 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $3.45K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #310 holding.
- Robertson Stephens Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 15 quarters since.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.